CONNECT WITH US
Tech

Tech

Mushrooms Tend to Be Deadly or Trippy. This One Is Both

Gizmodo - Tech logo

Published on

Add as a preferred source on Google
Mushrooms Tend to Be Deadly or Trippy. This One Is Both

In the swamps of Florida, there exists a tiny brown mushroom quite unlike anything humans have seen before: one that’s toxic and trippy at the same time.

In a study out today, researchers at the University of Florida and other institutions describe a mushroom that can pump out both deadly amatoxins and psilocybin, the active ingredient responsible for the psychedelic effects of recreationally used magic mushrooms. The genetics of this species—nicknamed the “dark magic mushroom”—may tell us something important about fungi and their evolution, the researchers said.

“Humanity’s cultural infatuation with mushrooms has long been bookended by two categories: mushrooms that induce psychedelic experiences and mushrooms that are deadly toxic. Our discovery of the ‘dark magic mushroom’ represents an unusual convergence of worlds, where we now know of this rare and unusual species that produces the chemistry responsible for both properties,” lead author Andrew Kunik, a fungal biologist at the University of Florida, told Gizmodo.

As is often the case in science, Kunik and his team’s discovery was more fortuitous than intentional.

The team originally set out to learn more about a broad and hard-to-distinguish group of fungi known as little brown mushrooms; they were specifically hoping to find species belonging to the genus Galerina that could produce amatoxins, one of the main compounds that make some mushrooms especially deadly to consume, including the aptly-named death cap mushroom (Amanita phalloides).

S. One of these specimens was an example of Galerina indica , a known but understudied species, and that’s when things got weird.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.